跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAX-4-A
首页
药物
MAX-4-A
MAX-4-A
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SUNSCREEN COMPOSITION
EP 2496208 B1
申请人: UNILEVER PLC
优先权: 2009
CN
EP
US
4 件公开
Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease
US 2007238787 A1
申请人: MYRIAD GENETICS INC
优先权: 2007
US
4 件公开
Black soybean polysaccharides
US 2005107452 A1
申请人: WANG SHENG-YUAN
优先权: 2002
US
2 件公开
Potent analogues of the C-Myc inhibitor 10074-G5 with improved cell permeability
US 9242944 B2
申请人: UNIV MARYLAND
优先权: 2014
US
2 件公开
Metal oxide in form of particles
CN 1766006 B
申请人: ICI PLC
优先权: 2000
CN
Process for making a colored make-up cosmetic composition with controlled transmittance
US 7023552 B2
申请人: OREAL
优先权: 2000
US
Peptide substrates for assay of extracellular signal-regulated protein kinase 1 and 2 activity
US 7037670 B2
申请人: UNIV LOUISIANA STATE
优先权: 2002
US
External pasted medication for curing nervus vascularis headache and perparation method of production
CN 1600327 B
申请人: JIANGUO ZHONG
优先权: 2003
CN
Chronotherapeutic compositions and methods of their use
US 2006003001 A1
申请人: DEVANE JOHN
优先权: 2005
US
Physiologically active substance NK13650P3, method of producing the same and use thereof
US 7803411 B2
申请人: NIPPON KAYAKU KK
优先权: 2005
US
第 1 / 3 页
上一页
下一页
药物
反馈